Saleem Sameer, Khan Adnan, Shafiq Ihtesham
Dr. Sameer Saleem, MBBS, Department of Medicine, Khyber Medical College, Peshawar, Pakistan.
Dr. Adnan khan, Final Year Students (MBBS), Rehman Medical College, Peshawar - Pakistan.
Pak J Med Sci. 2016 Jan-Feb;32(1):201-5. doi: 10.12669/pjms.321.8974.
To study the effect of timing of thrombolytic therapy, cardiac risk factors and site of infarction on S.T. resolution post thrombolysis in STEMI patients.
This was a descriptive hospital based study conducted at the Hayatabad Medical Complex Peshawar. The duration of our study was 5 months from February 2015 to June 2015. Diagnosis of STEMI in symptomatic patients was based on the ECG recognized. Definition of Myocardial Infarction. Time from onset of chest pain to presentation of patients in emergency was noted through history of patients along with time of streptokinase. ECG recordings of patients were taken upon presentation in Emergency. Serial ECG monitoring was done after administration of Streptokinase (SK). ST resolution was observed in the lead with the maximum ST elevation. Data were presented as frequencies and percentages, chi square test was applied.
Among 83 patients with STEMI 50.6% were males and 49.4% were females with the age group range of 30-83 years. Fifty nine patients (71.08%) with STEMI underwent thrombolysis within 12 hours of onset of chest pain while 24 patients (28.92%), underwent thrombolysis after 12 hours of onset of chest pain. Out of the 59 patients who received thrombolytic therapy before 12 hours, 43 (72.88%)completely resolved, while those who received thrombolytic therapy after 12 hours none of them completely resolved as per ECG findings. By applying chi-square test it gives us value of 36.470, and p-value <0.001. In our study 28 patients were diabetic and out of these six (21.43%) completely resolved as per ECG post thrombolysis, 9 (32.14%) partially resolved and 13 (46.43%) failed to resolve. On the other hand, in non-diabetics out of 55, 37 (67.27%) completely resolved, 12 (21.82%) partially resolved and 6 (10.91%) failed to resolve. Among 61 hypertensive, 26 (42.62%) had complete resolution and in 22 who were non-hypertensive, 17 (77.27%)had complete resolution on ECG. Hyperlipidemia and site of infarction didn't have statistically significant effect on the resolution of ECG post thrombolysis in STEMI patients.
Patients with diabetes, hypertension and those who receive thrombolysis after 12 hours of onset of chest pain respond poorly to thrombolytic therapy as per ECG findings whereas hyperlipidemia and site of infarction don't affect the response of STEMI patients to thrombolysis.
研究溶栓治疗时机、心脏危险因素及梗死部位对ST段抬高型心肌梗死(STEMI)患者溶栓后ST段回落的影响。
这是一项在白沙瓦哈亚塔巴德医疗中心开展的基于医院的描述性研究。研究持续时间为2015年2月至2015年6月共5个月。有症状患者的STEMI诊断基于公认的心电图及心肌梗死定义。通过患者病史记录胸痛发作至患者到急诊科就诊的时间以及链激酶使用时间。患者到急诊科就诊时进行心电图记录。给予链激酶(SK)后进行连续心电图监测。观察ST段抬高幅度最大的导联的ST段回落情况。数据以频数和百分比表示,应用卡方检验。
83例STEMI患者中,男性占50.6%,女性占49.4%,年龄范围为30 - 83岁。59例(71.08%)STEMI患者在胸痛发作12小时内接受溶栓治疗,24例(28.92%)在胸痛发作12小时后接受溶栓治疗。在12小时内接受溶栓治疗的59例患者中,43例(72.88%)ST段完全回落,而12小时后接受溶栓治疗的患者根据心电图结果无1例完全回落。通过卡方检验,得到值为36.470,p值<0.001。在本研究中,28例患者为糖尿病患者,其中6例(21.43%)溶栓后心电图显示ST段完全回落,9例(32.14%)部分回落,13例(46.43%)未回落。另一方面,55例非糖尿病患者中,37例(67.27%)完全回落,12例(21.82%)部分回落,6例(10.91%)未回落。61例高血压患者中,26例(42.62%)ST段完全回落,22例非高血压患者中,17例(77.27%)心电图显示ST段完全回落。高脂血症和梗死部位对STEMI患者溶栓后心电图回落无统计学显著影响。
根据心电图结果,糖尿病患者、高血压患者以及胸痛发作12小时后接受溶栓治疗的患者对溶栓治疗反应较差,而高脂血症和梗死部位不影响STEMI患者对溶栓治疗的反应。